Financial reports
10-Q
2024 Q2
Quarterly report
9 Aug 24
10-Q
2024 Q1
Quarterly report
20 May 24
NT 10-Q
Notice of late quarterly filing
15 May 24
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
10-Q
2023 Q3
Quarterly report
20 Nov 23
NT 10-Q
Notice of late quarterly filing
14 Nov 23
10-Q
2023 Q2
Quarterly report
16 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
Current reports
8-K
Entry into a Material Definitive Agreement
13 Sep 24
8-K
Other Events
5 Sep 24
8-K/A
Completion of Acquisition or Disposition of Assets
26 Aug 24
8-K
Entry into a Material Definitive Agreement
16 Aug 24
8-K
Departure of Directors or Certain Officers
2 Aug 24
8-K
Entry into a Material Definitive Agreement
19 Jul 24
8-K
Entry into a Material Definitive Agreement
18 Jun 24
8-K
Other Events
6 Jun 24
8-K
Entry into a Material Definitive Agreement
21 May 24
8-K
Entry into a Material Definitive Agreement
29 Apr 24
Other
EFFECT
Notice of effectiveness
15 Jul 24
UPLOAD
Letter from SEC
19 Jan 24
EFFECT
Notice of effectiveness
14 Oct 22
CERT
Certification of approval for exchange listing
13 Oct 22
CORRESP
Correspondence with SEC
11 Oct 22
CORRESP
Correspondence with SEC
11 Oct 22
CORRESP
Correspondence with SEC
29 Jul 22
UPLOAD
Letter from SEC
26 Jul 22
CORRESP
Correspondence with SEC
12 May 22
CORRESP
Correspondence with SEC
12 May 22
Ownership
SC 13G/A
WOLVERINE ASSET MANAGEMENT LLC
5 Sep 24
4/A
Leonard L Mazur
30 Aug 24
4/A
MYRON Z HOLUBIAK
30 Aug 24
4/A
Myron Czuczman
30 Aug 24
4/A
Jaime Bartushak
30 Aug 24
SC 13D
Citius Pharmaceuticals, Inc.
16 Aug 24
4
Eugene Myron Holuka
16 Aug 24
3
Eugene Myron Holuka
16 Aug 24
SC 13D/A
10XYZ Holdings LP
15 Aug 24
4
Suren G Dutia
14 Aug 24